Related Experiment Videos
Acute interstitial pneumonia
1Lung and Upper Aerodigestive Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. vourlekj@mail.nih.gov
Clinics in Chest Medicine
|November 27, 2004
Summary
Acute interstitial pneumonia (AIP) presents rapidly, unlike other idiopathic interstitial pneumonias. While initially severe, survivors may have a better long-term outlook.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Interstitial Lung Diseases
Background:
- Idiopathic interstitial pneumonias (IIPs) are lung diseases with unknown causes, often leading to pulmonary fibrosis and reduced life expectancy.
- IIP symptoms typically develop gradually.
- Effective therapies for most IIPs are lacking.
Purpose of the Study:
- To review acute interstitial pneumonia (AIP), also known as acute interstitial pneumonitis.
- To clarify AIP's unique characteristics and its position within the spectrum of IIPs.
- To highlight the limited progress in understanding AIP despite its description nearly two decades ago.
Main Methods:
- Literature review focusing on acute interstitial pneumonia (AIP).
- Analysis of AIP's clinical presentation, prognosis, and comparison with other idiopathic interstitial pneumonias.
- Synthesis of current knowledge regarding AIP.
Main Results:
- Acute interstitial pneumonia (AIP) is distinguished by its rapid, fulminant onset.
- AIP is associated with high initial mortality but potentially better long-term outcomes for survivors.
- Knowledge regarding AIP has advanced minimally since its initial description.
Conclusions:
- Acute interstitial pneumonia (AIP) represents a distinct entity within the idiopathic interstitial pneumonias.
- Despite its rapid onset and severity, AIP may offer a more favorable prognosis for survivors compared to other IIPs.
- Further research is needed to improve understanding and treatment of AIP.